Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?
about
Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.Pharmacogenetics in Ghana: reviewing the evidence.Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.Cytochrome P450 pharmacogenetics in African populations.African variation at Cytochrome P450 genes: Evolutionary aspects and the implications for the treatment of infectious diseases.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.Genetic polymorphisms of the drug-metabolizing enzyme cytochrome P450 3A5 in a Uyghur Chinese population.S1 guidelines on the diagnosis and treatment of scabies - short version.Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans.Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers.S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung.Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.Onchodermatitis: Where Are We Now?
P2860
Q34491448-87D6F678-13D3-4990-B11B-14B765561354Q35172002-A14CF35B-FCE6-4718-B5DE-19E478893B7CQ35584999-7B1277D6-84E3-4E7B-A0CF-700DFA566A0EQ37715233-AA450428-FF66-4EDE-BF32-080C81CE6BEFQ38099372-54009E07-D5BF-4279-A292-16EC0B5356D3Q38183664-E9079CEB-A06A-4513-81B2-68E6BFC2B18EQ38192688-8F57F35D-347C-4E01-A481-2B9B6E184A76Q38936568-672B403C-7743-45A3-AEED-A422AB447A75Q40135202-BD4776EE-A218-4301-8D29-ADA9E6DB5537Q40438834-4B46FBDE-D519-4A1C-8FFD-67519744089FQ40650904-19C53D87-6095-4978-BF7F-96F469D2D19DQ43759147-23811555-5567-4708-91F0-F7932BF35914Q48218312-F29456BD-AFAD-4F6A-8229-6BE3D3B3696EQ52767008-1D3F6DBD-7C28-4D82-A44F-78BD0BF76AA1Q54435691-DCD94E8E-6D83-4069-9066-2997774DB29BQ57130087-8FE8B60C-27D4-4129-86FA-689FCD4E06F2
P2860
Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic polymorphisms in MDR1, ...... olism of ivermectin in humans?
@ast
Genetic polymorphisms in MDR1, ...... olism of ivermectin in humans?
@en
type
label
Genetic polymorphisms in MDR1, ...... olism of ivermectin in humans?
@ast
Genetic polymorphisms in MDR1, ...... olism of ivermectin in humans?
@en
prefLabel
Genetic polymorphisms in MDR1, ...... olism of ivermectin in humans?
@ast
Genetic polymorphisms in MDR1, ...... olism of ivermectin in humans?
@en
P2093
P2860
P356
P1433
P1476
Genetic polymorphisms in MDR1, ...... olism of ivermectin in humans?
@en
P2093
Alexander N O Dodoo
Jeremy J Mills
William Kudzi
P2860
P2888
P356
10.1186/1471-2350-11-111
P577
2010-07-14T00:00:00Z
P5875
P6179
1022814896